Research Article

Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus

Table 1

Clinical and biochemical characteristics of nT2DM patients with and without MetS.

CovariateWithout MetS ()With MetS () value

Male/female65/6883/950.696
Age (years)53.21 ± 10.3654.06 ± 9.860.464
BMI (kg/m2)22.71 ± 2.4326.96 ± 3.24<0.001
BF% (%)26.10 ± 4.8731.06 ± 4.61<0.001
SBP (mmHg)121.84 ± 9.90129.79 ± 16.34<0.001
DBP (mmHg)71.99 ± 8.6276.42 ± 9.48<0.001
FPG (mmol/l)10.11 ± 3.7611.00 ± 3.590.036
2hPG (mmol/l)17.38 ± 8.3218.57 ± 5.640.017
HbA1c (%)9.37 ± 2.839.38 ± 1.980.957
TC (mmol/l)4.29 ± 0.934.77 ± 1.620.040
TG (mmol/l)1.30 ± 0.622.85 ± 2.26<0.001
HDL-C (mmol/l)1.31 ± 0.291.00 ± 0.34<0.001
LDL-C (mmol/l)2.63 ± 0.802.78 ± 1.020.147
apoA (g/l)1.53 ± 0.331.36 ± 0.26<0.001
apoB (g/l)0.84 ± 0.210.97 ± 0.29<0.001
ALT (U/l)22.03 ± 13.4525.26 ± 13.870.006
AST (U/l)21.72 ± 13.0522.30 ± 10.530.139
GGT (U/l)35.81 ± 6.2140.75 ± 2.81<0.001
ALP (U/l)88.94 ± 44.4783.06 ± 38.150.389
WBC (×109/l)6.52 ± 1.777.22 ± 2.560.004
Neutrophil (×109/l)4.45 ± 1.594.91 ± 2.420.148
Lymphocyte (×109/l)1.51 ± 0.551.68 ± 0.580.010
NLR3.51 ± 0.253.58 ± 0.290.317
hs-CRP (mg/l)5.98 ± 1.336.34 ± 0.960.007
FIns (μU/ml)8.45 ± 4.6811.04 ± 7.260.002
HOMA-IR3.80 ± 2.615.30 ± 3.92<0.001
HOMA-IS39.98 ± 37.3339.63 ± 41.680.619
TyG index4.94 ± 0.305.29 ± 0.47<0.001
apoB/apoA0.57 ± 0.190.73 ± 0.23<0.001

BMI: body mass index; BF%: body fat percentage; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; 2hPG: 2 h plasma glucose; HbA1c: glycated hemoglobin A1c; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; apoA: apolipoprotein A; apoB: apolipoprotein B; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyltransferase; ALP: alkaline phosphatase; WBC: white blood cell; NLR: neutrophil to lymphocyte ratio; hs-CRP: high-sensitivity C-reactive protein; FIns: fasting plasma insulin; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-IS: homeostasis model assessment of β-cell insulin secretion; apoB/apoA: apolipoprotein A/apolipoprotein B; TyG: triglyceride glucose.